MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
3. Results
3.1. Up- and Downregulated microRNAs in Papillary Thyroid Cancer
3.2. One Gene Can Be Targeted by Several microRNAs
3.3. One MicroRNA Can Target Several mRNAs/Genes
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Dragomir, M.; Mafra, A.C.P. Using microRNA Networks to Understand Cancer. Int. J. Mol. Sci. 2018, 19, 1871. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zembska, A.; Jawiarczyk-Przybyłowska, A. MicroRNA Expression in the Progression and Aggressiveness of Papillary Thyroid Carcinoma. Anticancer Res. 2019, 39, 33–40. [Google Scholar] [CrossRef] [PubMed]
- Farazi, T.; Hoell, J. MicroRNAs in human cancer. Adv. Exp. Med. Biol. 2013, 774, 1–20. [Google Scholar] [PubMed] [Green Version]
- Zhang, Y.; Xu, D. Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma. Oncol. Lett. 2017, 13, 4252–4266. [Google Scholar] [CrossRef]
- Santiago, K.; Chen Wongworawat, Y. Differential MicroRNA-Signatures in Thyroid Cancer Subtypes. J. Oncol. 2020, 2020, 2052396. [Google Scholar] [CrossRef]
- Piciu, D.; Irimie, A. Investigation of thyroid carcinoma over 40 years, using the database of the Ion Chiricuta Institute of Oncology Cluj-Napoca. J. BUON 2014, 19, 524–529. [Google Scholar]
- Fugazzola, L.; Elisei, R. 2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer. Eur. Thyroid J. 2019, 8, 227–245. [Google Scholar] [CrossRef]
- Haugen, B.R.; Alexander, E.K. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016, 26, 1–133. [Google Scholar] [CrossRef] [Green Version]
- Zhang, Y.; Pan, J. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma. Oncol. Rep. 2018, 40, 3611–3624. [Google Scholar] [CrossRef] [Green Version]
- Piciu, D.; Irimie, A. Diagnostic and treatment guidelines in thyroid carcinoma. American and Europeanconsensus, adapted to Romania. Acta. Endodontol. 2007, 3, 103–115. [Google Scholar]
- Filetti, S.; Durante, C. ESMO Guidelines Committee. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann. Oncol. 2019, 30, 1856–1883. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bi, C.L.; Zhang, Y.Q. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway. J. Cell Physiol. 2019, 234, 4054–4067. [Google Scholar] [CrossRef] [PubMed]
- Cai, X.; Zhao, Z. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression. Cell Death Dis. 2019, 10, 184. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cao, X.Z.; Bin, H. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1. Biomed Pharmacother 2019, 109, 1960–1966. [Google Scholar] [CrossRef]
- Chen, F.; Yin, S. lncRNA DGCR5 acts as a tumor suppressor in papillary thyroid carcinoma via sequestering miR-2861. Exp. Ther. Med. 2019, 17, 895–900. [Google Scholar] [CrossRef]
- Chen, F.; Yang, D. MicroRNA-101 Targets CXCL12-Mediated Akt and Snail Signaling Pathways to Inhibit Cellular Proliferation and Invasion in Papillary Thyroid Carcinoma. Oncol. Res. 2019, 27, 691–701. [Google Scholar] [CrossRef]
- Chen, N.; Yin, D. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis. Biosci. Rep. 2019, 39, BSR20181440. [Google Scholar] [CrossRef] [Green Version]
- Chen, J.; Yin, J. MiR-202-3p functions as a tumor suppressor and reduces cell migration and invasion in papillary thyroid carcinoma. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 1145–1150. [Google Scholar]
- Chen, Y.; Hao, S.A. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 7989–7999. [Google Scholar]
- Cui, Z.; Luo, Z. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis. J. Gene Med. 2019, 21, e3083. [Google Scholar] [CrossRef]
- Du, Y.; Zhu, J. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 6570–6578. [Google Scholar] [PubMed]
- Fa, Z.; Min, Z. MicroRNA-150 suppresses the growth and malignant behavior of papillary thyroid carcinoma cells via downregulation of MUC4. Exp. Ther. Med. 2018, 16, 45–52. [Google Scholar] [CrossRef] [PubMed]
- Fang, T.; Li, J. Shenmai injection improves the postoperative immune function of papillary thyroid carcinoma patients by inhibiting differentiation into Treg cells via miR-103/GPER1 axis. Drug Dev. Res. 2018, 79, 324–331. [Google Scholar] [CrossRef] [PubMed]
- Fang, L.; Kong, D. MicroRNA-625-3p promotes the proliferation, migration and invasion of thyroid cancer cells by up-regulating astrocyte elevated gene 1. Biomed Pharmacother 2018, 102, 203–211. [Google Scholar] [CrossRef]
- Fang, M.; Huang, W. MiR-141-3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer via Targeting Yin Yang 1. Anat Rec. (Hoboken) 2019, 302, 258–268. [Google Scholar] [CrossRef]
- Feng, L.; Yang, B. Long noncoding RNA LINC00460 promotes carcinogenesis via sponging miR-613 in papillary thyroid carcinoma. J. Cell Physiol. 2019, 234, 11431–11439. [Google Scholar] [CrossRef] [Green Version]
- Feng, Z.; Chen, R. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma. Life Sci. 2020, 244, 117298. [Google Scholar] [CrossRef]
- Fu, Y.T.; Zheng, H.B. MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting FGFR2. Eur. Rev. Med. Pharmacol. Sci. 2018, 22, 3430–3438. [Google Scholar]
- Gao, X.; Chen, Z. MiR-129 regulates growth and invasion by targeting MAL2 in papillary thyroid carcinoma. Biomed Pharmacother 2018, 105, 1072–1078. [Google Scholar] [CrossRef]
- Gao, X.B.; Chen, C.L. MicroRNA-791 is an independent prognostic factor of papillary thyroid carcinoma and inhibits the proliferation of PTC cells. Eur. Rev. Med. Pharmacol. Sci. 2018, 22, 5562–5568. [Google Scholar]
- Gao, H.; Sun, X. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer. Cell Cycle 2020, 19, 1186–1199. [Google Scholar] [CrossRef]
- Guo, H.; Zhang, L. MicroRNA-30a suppresses papillary thyroid cancer cell proliferation, migration and invasion by directly targeting E2F7. Exp. Ther. Med. 2019, 18, 209–215. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Guo, F.; Hou, X. MicroRNA-9-5p functions as a tumor suppressor in papillary thyroid cancer via targeting BRAF. Oncol. Lett. 2018, 16, 6815–6821. [Google Scholar] [CrossRef] [PubMed]
- Han, J.; Zhang, M. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1. Cell Death Dis. 2019, 10, 195. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- He, T.; Wang, H. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules. BMC Endocr. Disord. 2019, 19, 122. [Google Scholar] [CrossRef]
- Hu, Z.; Zhao, P. Hsa_circ_0011290 regulates proliferation, apoptosis and glycolytic phenotype in papillary thyroid cancer via miR-1252/FSTL1 signal pathway. Arch. Biochem. Biophys. 2020, 685, 108353. [Google Scholar] [CrossRef] [PubMed]
- Jiao, X.; Ye, J. KIAA1199, a Target of MicoRNA-486-5p, Promotes Papillary Thyroid Cancer Invasion by Influencing Epithelial-Mesenchymal Transition (EMT). Med. Sci. Monit. 2019, 25, 6788–6796. [Google Scholar] [CrossRef] [PubMed]
- Jin, X.; Wang, Z. Upregulated hsa_circ_0004458 Contributes to Progression of Papillary Thyroid Carcinoma by Inhibition of miR-885-5p and Activation of RAC1. Med. Sci. Monit. 2018, 24, 5488–5500. [Google Scholar] [CrossRef]
- Jin, J.; Zhang, J. miRNA-15a regulates the proliferation and apoptosis of papillary thyroid carcinoma via regulating AKT pathway. Onco. Targets. Ther. 2019, 12, 6217–6226. [Google Scholar] [CrossRef] [Green Version]
- Kong, W.; Yang, L. MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma. Eur. Rev. Med. Pharmacol. Sci. 2018, 22, 3804–3811. [Google Scholar]
- Li, G.; Kong, Q. LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis. Biol. Res. 2019, 52, 61. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, M.; Qu, L. Propofol upregulates miR-320a and reduces HMGB1 by downregulating ANRIL to inhibit PTC cell malignant behaviors. Pathol. Res. Pract. 2020, 216, 152856. [Google Scholar] [CrossRef] [PubMed]
- Li, P.; Dong, M. Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC). Bosn. J. Basic. Med. Sci. 2019, 19, 146–154. [Google Scholar] [CrossRef] [Green Version]
- Li, D.; Wang, Q. miR 205 targets YAP1 and inhibits proliferation and invasion in thyroid cancer cells. Mol. Med. Rep. 2018, 18, 1674–1681. [Google Scholar] [CrossRef]
- Li, X.; Zhong, W. Silencing of lncRNA LINC00514 inhibits the malignant behaviors of papillary thyroid cancer through miR-204-3p/CDC23 axis. Biochem. Biophys. Res. Commun. 2019, 508, 1145–1148. [Google Scholar] [CrossRef] [PubMed]
- Li, R.; Dong, B. MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1. Biomed. Pharmacother 2018, 102, 988–995. [Google Scholar] [CrossRef] [PubMed]
- Li, R.; Teng, X. MiR-4500 Regulates PLXNC1 and Inhibits Papillary Thyroid Cancer Progression. Horm. Cancer 2019, 10, 150–160. [Google Scholar] [CrossRef] [PubMed]
- Liang, M.; Jia, J. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer. Endocrine 2019, 65, 318–326. [Google Scholar] [CrossRef]
- Liu, C.; Feng, Z. Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway. Cell Cycle 2019, 18, 167–203. [Google Scholar] [CrossRef] [Green Version]
- Liu, F.; Lou, K. miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10. Int. J. Mol. Med. 2018, 42, 3027–3036. [Google Scholar] [CrossRef] [Green Version]
- Liu, H.; Guo, J. MicroRNA 744 suppresses cell proliferation and invasion of papillary thyroid cancer by directly targeting NOB1. Mol. Med. Rep. 2019, 19, 1903–1910. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, Z.M.; Wu, Z.Y. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 3421–3430. [Google Scholar] [PubMed]
- Liu, Z.; Zhang, J. MicroRNA-4728 mediated regulation of MAPK oncogenic signaling in papillary thyroid carcinoma. Saudi J. Biol. Sci. 2018, 25, 986–990. [Google Scholar] [CrossRef]
- Liu, Y.; Li, L. Downregulation of MiR-431 expression associated with lymph node metastasis and promotes cell invasion in papillary thyroid carcinoma. Cancer Biomark 2018, 22, 727–732. [Google Scholar] [CrossRef]
- Liu, H.; Chen, X. MicroRNA-524-5p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways. J. Cell Physiol. 2019, 234, 18382–18391. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, S.; Zhang, D. Long non-coding RNA BRM promotes proliferation and invasion of papillary thyroid carcinoma by regulating the microRNA-331-3p/SLC25A1 axis. Oncol. Lett. 2020, 19, 3071–3078. [Google Scholar] [CrossRef]
- Luo, L.; Xia, L. miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells. Biomed. Pharmacother 2018, 106, 983–990. [Google Scholar] [CrossRef]
- Long, M.; Zhu, Y. Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1α and microRNA-146a. J. Clin. Endocrinol. Metab. 2020, 105, dgaa182. [Google Scholar] [CrossRef]
- Ma, Y.; Sun, Y. miR-29a-3p inhibits growth, proliferation, and invasion of papillary thyroid carcinoma by suppressing NF-κB signaling via direct targeting of OTUB2. Cancer Manag. Res. 2018, 11, 13–23. [Google Scholar] [CrossRef] [Green Version]
- Ma, S.; Jia, W. miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1. Biochem. Biophys. Res. Commun. 2018, 497, 181–186. [Google Scholar] [CrossRef]
- Pan, Y.; Zhu, X. MicroRNA-363-3p suppresses anoikis resistance in human papillary thyroid carcinoma via targeting integrin alpha 6. Acta Biochim. Biophys. Sin. (Shanghai) 2019, 51, 807–813. [Google Scholar] [CrossRef] [PubMed]
- Pan, Y.; Xu, T. Upregulated circular RNA circ_0025033 promotes papillary thyroid cancer cell proliferation and invasion via sponging miR-1231 and miR-1304. Biochem. Biophys. Res. Commun. 2019, 510, 334–338. [Google Scholar] [CrossRef]
- Peng, Y.; Fang, X. MiR-146b-5p Regulates the Expression of Long Noncoding RNA MALAT1 and Its Effect on the Invasion and Proliferation of Papillary Thyroid Cancer. Cancer Biother Radiopharm 2020. [Google Scholar] [CrossRef] [PubMed]
- Pu, Y.; Xiang, J. KDM5B-mediated microRNA-448 up-regulation restrains papillary thyroid cancer cell progression and slows down tumor growth via TGIF1 repression. Life Sci. 2020, 250, 117519. [Google Scholar] [CrossRef] [PubMed]
- Ren, L.; Xu, Y. miR-199b-5p-Stonin 2 axis regulates metastases and epithelial-to-mesenchymal transition of papillary thyroid carcinoma. IUBMB Life 2019, 71, 28–40. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shi, D.; Wang, H. MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma. Onco. Targets Ther. 2019, 12, 6605–6616. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Song, Z.; Yang, H. microRNA-564 inhibits the aggressive phenotypes of papillary thyroid cancer by directly targeting astrocyte-elevated gene-1. Onco. Targets. Ther. 2019, 12, 4869–4881. [Google Scholar] [CrossRef] [Green Version]
- Sui, G.; Zhang, B. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis. J. Cell Physiol. 2020, 235, 6615–6624. [Google Scholar] [CrossRef]
- Sun, W.; Lan, X. MicroRNA-144 inhibits proliferation by targeting WW domain-containing transcription regulator protein 1 in papillary thyroid cancer. Oncol. Lett. 2018, 15, 1007–1013. [Google Scholar] [CrossRef] [Green Version]
- Sun, W.; Lan, X. NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer. Cell Death Dis. 2018, 9, 380. [Google Scholar] [CrossRef]
- Sun, Y.; Zhang, L. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma. Cell Biochem. Funct. 2020. [CrossRef] [PubMed]
- Sun, Y.; Shi, T. Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression. Cell Cycle 2020, 19, 787–800. [Google Scholar] [CrossRef] [PubMed]
- Sun, Y.H.; Liu, Z.F. MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 8429–8439. [Google Scholar]
- Sun, Z.; Guo, X. Long non-coding RNA LINC00152 promotes cell growth and invasion of papillary thyroid carcinoma by regulating the miR-497/BDNF axis. J. Cell Physiol. 2019, 234, 1336–1345. [Google Scholar] [CrossRef] [PubMed]
- Wang, D.; Guo, C. Serum miR-22 may be a biomarker for papillary thyroid cancer. Oncol. Lett. 2019, 17, 3355–3361. [Google Scholar] [CrossRef] [Green Version]
- Wang, D.P.; Tang, X.Z. microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway. J. Cell Physiol. 2020, 235, 2492–2505. [Google Scholar] [CrossRef]
- Wang, G.; Wang, X. LINC01410/miR-3619-5p/FOXM1 Feedback Loop Regulates Papillary Thyroid Carcinoma Cell Proliferation and Apoptosis. Cancer Biother. Radiopharm. 2019, 34, 572–580. [Google Scholar] [CrossRef] [PubMed]
- Wang, J.; Xiao, T. MicroRNA-675 directly targets MAPK1 to suppress the oncogenicity of papillary thyroid cancer and is sponged by long non-coding RNA RMRP. Onco. Targets Ther. 2019, 12, 7307–7321. [Google Scholar] [CrossRef] [Green Version]
- Wang, L.J.; Cai, H.Q. miR-1258: A novel microRNA that controls TMPRSS4 expression is associated with malignant progression of papillary thyroid carcinoma. Endokrynol. Pol. 2020, 71, 146–152. [Google Scholar] [CrossRef] [Green Version]
- Wang, Q.; Shang, J. MiR-451a restrains the growth and metastatic phenotypes of papillary thyroid carcinoma cells via inhibiting ZEB1. Biomed. Pharmacother 2020, 127, 109901. [Google Scholar] [CrossRef]
- Wang, R.; Ma, Q. miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma. Onco. Targets Ther. 2018, 11, 1501–1509. [Google Scholar] [PubMed] [Green Version]
- Wang, R.; Zhao, L. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212. Biomed Pharmacother 2019, 118, 109298. [Google Scholar] [CrossRef] [PubMed]
- Wang, X.; Qi, M. miR-718 is involved in malignancy of papillary thyroid cancer through repression of PDPK1. Pathol. Res. Pract. 2018, 214, 1787–1793. [Google Scholar] [CrossRef]
- Wang, Y.; Liu, B.G. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 5863–5873. [Google Scholar] [PubMed]
- Wang, Y.; Wang, B. MicroRNA-384 Inhibits the Progression of Papillary Thyroid Cancer by Targeting PRKACB. Biomed Res. Int. 2020, 2020, 4983420. [Google Scholar] [CrossRef] [Green Version]
- Wang, Z.; Liu, W. miR-873-5p Inhibits Cell Migration and Invasion of Papillary Thyroid Cancer via Regulation of CXCL16. Onco. Targets Ther. 2020, 13, 1037–1046. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, Z.L.; Wang, C. Upregulation of microRNA-143-3p induces apoptosis and suppresses proliferation, invasion, and migration of papillary thyroid carcinoma cells by targeting MSI2. Exp. Mol. Pathol. 2020, 112, 104342. [Google Scholar] [CrossRef]
- Wei, H.; Pan, L. Circular RNA circZFR contributes to papillary thyroid cancer cell proliferation and invasion by sponging miR-1261 and facilitating C8orf4 expression. Biochem. Biophys. Res. Commun. 2018, 503, 56–61. [Google Scholar] [CrossRef]
- Wu, D.M.; Wang, S. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma. Cell Death Dis. 2018, 9, 947. [Google Scholar] [CrossRef]
- Wu, L.; Pei, F. miR-329 inhibits papillary thyroid cancer progression via direct targeting WNT1. Oncol. Lett. 2018, 16, 3561–3568. [Google Scholar] [CrossRef] [Green Version]
- Wu, X.; Dai, L. Overexpression of microRNA-203 can downregulate survivin and function as a potential therapeutic target in papillary thyroid cancer. Oncol. Lett. 2020, 19, 61–68. [Google Scholar] [CrossRef] [Green Version]
- Wu, Y.C.; Li, S.Y. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 8940–8949. [Google Scholar]
- Xiang, D.; Tian, B. miR-222 expression is correlated with the ATA risk stratifications in papillary thyroid carcinomas. Medicine (Baltimore) 2019, 98, e16050. [Google Scholar] [CrossRef]
- Yan, R.; Yang, T. MicroRNA-150-5p affects cell proliferation, apoptosis, and EMT by regulation of the BRAFV600E mutation in papillary thyroid cancer cells. J. Cell Biochem. 2018, 119, 8763–8772. [Google Scholar] [CrossRef]
- Yang, C.; Liu, Z. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma. J. Cell Biochem. 2020, 121, 2009–2018. [Google Scholar] [CrossRef]
- Yao, X.G.; Tan, Q. Tissue microRNA-182 expression level and its potential prognostic value for papillary thyroid carcinoma. Int. J. Clin. Exp. Pathol. 2019, 12, 3128–3133. [Google Scholar] [PubMed]
- Ye, M.; Hou, H. Circular RNA circFOXM1 Plays a Role in Papillary Thyroid Carcinoma by Sponging miR-1179 and Regulating HMGB1 Expression. Mol. Ther. Nucleic Acids 2020, 19, 741–750. [Google Scholar] [CrossRef] [PubMed]
- Yi, T.; Zhou, X. MicroRNA-1270 modulates papillary thyroid cancer cell development by regulating SCAI. Biomed Pharmacother 2019, 109, 2357–2364. [Google Scholar] [CrossRef]
- Yin, X.; Zhang, J. LncRNA HOXA11-AS accumulation-induced microRNA-761 downregulation regulates cell growth by targeting TRIM29 in papillary thyroid cancer. Am. J. Transl. Res. 2019, 11, 6826–6837. [Google Scholar]
- Yin, J.J.; Cheng, X.Y. MicroRNA-23a inhibits the growth of papillary thyroid carcinoma via regulating cyclin G1. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 3431–3439. [Google Scholar]
- You, A.; Fu, L. MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3. Cell Cycle 2020, 19, 1105–1121. [Google Scholar] [CrossRef] [PubMed]
- Yu, S.; Cao, S. miR-3619-3p promotes papillary thyroid carcinoma progression via Wnt/β-catenin pathway. Ann. Transl. Med. 2019, 7, 643. [Google Scholar] [CrossRef]
- Yuan, Q.; Liu, Y. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637. Int. J. Biochem. Cell Biol. 2018, 98, 1–9. [Google Scholar] [CrossRef] [PubMed]
- Zang, C.; Sun, J. miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma. Hum. Cell 2019, 32, 428–436. [Google Scholar] [CrossRef]
- Zang, C.S.; Huang, H.T. MiR-224-5p targets EGR2 to promote the development of papillary thyroid carcinoma. Eur. Rev. Med. Pharmacol. Sci. 2020, 24, 4890–4900. [Google Scholar]
- Zhang, S.; Wang, Q. MicroRNA 509 targets PAX6 to inhibit cell proliferation and invasion in papillary thyroid carcinoma. Mol. Med. Rep. 2019, 19, 1403–1409. [Google Scholar] [CrossRef] [PubMed]
- Zhao, J.; Li, Z. MicroRNA 766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway. Int. J. Oncol. 2019, 54, 315–325. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhao, X.; Li, Y. MicroRNA-96-3p promotes metastasis of papillary thyroid cancer through targeting SDHB. Cancer Cell Int. 2019, 19, 287. [Google Scholar] [CrossRef]
- Zhao, Y.; Zhao, L. Silencing of long noncoding RNA RP11-476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA-138-5p-dependent inhibition of LRRK2. J. Cell Physiol. 2019, 234, 20980–20991. [Google Scholar] [CrossRef]
- Zhao, Z.; Yang, F. MicroRNA-409-3p suppresses cell proliferation and cell cycle progression by targeting cyclin D2 in papillary thyroid carcinoma. Oncol. Lett. 2018, 16, 5237–5242. [Google Scholar] [CrossRef] [Green Version]
- Zhou, B.; Xu, J. miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathway. Exp. Cell Res. 2020, 387, 111785. [Google Scholar] [CrossRef]
- Zhou, P.; Irving, A. Validation of MicroRNA-188-5p Inhibition Power on Tumor Cell Proliferation in Papillary Thyroid Carcinoma. Cell Transplant. 2020, 29, 963689720918300. [Google Scholar] [CrossRef]
- Zhu, J.; Zhang, Q. MiR-506 suppresses papillary thyroid carcinoma cell proliferation and metastasis via targeting IL17RD. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 2856–2862. [Google Scholar] [PubMed]
- Liao, B.; Liu, S. Long Noncoding RNA CTC Inhibits Proliferation and Invasion by Targeting miR-146 to Regulate KIT in Papillary Thyroid Carcinoma. Sci. Rep. 2020, 10, 4616. [Google Scholar] [CrossRef]
- Wu, G.; Zhou, W. Circular RNA Profiling Reveals Exosomal circ_0006156 as a Novel Biomarker in Papillary Thyroid Cancer. Mol. Ther. Nucleic Acids 2020, 19, 1134–1144. [Google Scholar] [CrossRef]
- Yang, Z.; Li, G. Long non-coding RNA HULC exerts oncogenic activity on papillary thyroid cancer in vitro and in vivo. Artif Cells Nanomed. Biotechnol. 2020, 48, 326–335. [Google Scholar]
- Li, Q.; Wang, X.J. SOX2-induced upregulation of lncRNA LINC01510 promotes papillary thyroid carcinoma progression by modulating miR-335/SHH and activating Hedgehog pathway. Biochem. Biophys. Res. Commun. 2019, 520, 277–283. [Google Scholar] [CrossRef]
- Zhuang, X.; Tong, H. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis. Cell Death Dis. 2019, 10, 620. [Google Scholar] [CrossRef] [Green Version]
- Feng, J.; Zhou, Q. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3. Cell Death Dis. 2019, 10, 433. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wei, Z.L.; Gao, A.B. MicroRNA-221 promotes papillary thyroid carcinoma cell migration and invasion via targeting RECK and regulating epithelial-mesenchymal transition. Onco. Targets Ther. 2019, 12, 2323–2333. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, F.; Yin, R. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma. Biomed. Pharmacother 2019, 114, 108605. [Google Scholar] [CrossRef] [PubMed]
- Wu, F.; Li, F. Exosomes increased angiogenesis in papillary thyroid cancer microenvironment. Endocr. Relat. Cancer 2019, 26, 525–538. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ye, W.; Deng, X. Exosomal miRNA423-5p mediated oncogene activity in papillary thyroid carcinoma: A potential diagnostic and biological target for cancer therapy. Neoplasma 2019, 66, 516–523. [Google Scholar] [CrossRef] [PubMed]
- Yan, D.G.; Liu, N. SP1-induced upregulation of long noncoding RNA LINC00313 contributes to papillary thyroid cancer progression via the miR-422a. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 1134–1144. [Google Scholar]
- Wen, J.; Wang, H. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway. Cell Prolif. 2019, 52, e12569. [Google Scholar] [CrossRef] [Green Version]
- Huang, J.; Lin, H. Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma. Med. Sci. Monit. 2018, 24, 8899–8909. [Google Scholar] [CrossRef]
- Ding, C.; Yu, H. MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma. Biomed Pharmacother 2019, 110, 528–536. [Google Scholar] [CrossRef]
- Jia, M.; Shi, Y. MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma development by targeting CCDC6. Cancer Lett. 2019, 443, 145–156. [Google Scholar] [CrossRef]
- Li, X.; Tian, Y. CircNUP214 sponges miR-145 to promote the expression of ZEB2 in thyroid cancer cells. Biochem. Biophys. Res. Commun. 2018, 507, 168–172. [Google Scholar] [CrossRef]
- Xia, F.; Chen, Y. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway. Cell Physiol. Biochem. 2018, 50, 1659–1672. [Google Scholar] [CrossRef]
- Jiang, L.; Wu, Z. LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis. Hum. Gene Ther. 2019, 30, 618–631. [Google Scholar] [CrossRef]
- Yu, C.; Zhang, L. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting NF2 in Human Papillary Thyroid Cancer. Thyroid 2018, 28, 1627–1641. [Google Scholar] [CrossRef] [PubMed]
- Wang, M.; Chen, B. CircRNA circ-ITCH suppresses papillary thyroid cancer progression through miR-22-3p/CBL/β-catenin pathway. Biochem. Biophys. Res. Commun. 2018, 504, 283–288. [Google Scholar] [CrossRef] [PubMed]
- Zhao, L.; Zhang, X. Matrine inhibits TPC-1 human thyroid cancer cells via the miR-21/PTEN/Akt pathway. Oncol. Lett. 2018, 16, 2965–2970. [Google Scholar] [CrossRef] [PubMed]
- Li, D.; Cui, C. Long non coding RNA UCA1 promotes papillary thyroid cancer cell proliferation via miR 204 mediated BRD4 activation. Mol. Med. Rep. 2018, 18, 3059–3067. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wu, W.J.; Yin, H. Long noncoding RNA LINC00313 modulates papillary thyroid cancer tumorigenesis via sponging miR-4429. Neoplasma 2018, 65, 933–942. [Google Scholar] [CrossRef]
- Huang, Y.; Yu, S. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression. Thyroid 2018, 28, 1162–1173. [Google Scholar] [CrossRef]
- Zhang, H.; Cai, Y. LncRNA BISPR promotes the progression of thyroid papillary carcinoma by regulating miR-21-5p. Int. J. Immunopathol. Pharmacol. 2018, 32, 2058738418772652. [Google Scholar] [CrossRef]
- Feng, K.; Liu, Y. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor. Biomed. Pharmacother 2018, 104, 686–698. [Google Scholar] [CrossRef]
- Zhang, H.; Cai, Y. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression. J. Cell Physiol. 2018, 233, 6638–6648. [Google Scholar] [CrossRef]
- Jiang, K.; Li, G. Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas. Onco. Targets Ther. 2020, 13, 1311–1319. [Google Scholar] [CrossRef] [Green Version]
- Xu, C.B.; Liu, X.S. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor. J. Cell Biochem. 2019, 120, 10830–10846. [Google Scholar] [CrossRef] [PubMed]
- Chen, Z.B.; Cao, W.L. MIR22HG inhibits cell growth, migration and invasion through regulating the miR-24-3p/p27kip1 axis in thyroid papillary carcinomas. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 5851–5862. [Google Scholar] [PubMed]
- Gong, Y.; Wu, W. MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19. Am. J. Cancer Res. 2018, 8, 1030–1039. [Google Scholar] [PubMed]
- Qiu, K.; Xie, Q. miR-98-5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax/Caspase-3 by HMGA2. J. Clin. Lab. Anal. 2020, 34, e2304. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhou, S.L.; Tang, Q.L. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 2084–2091. [Google Scholar] [PubMed]
- Fan, X.; Zhao, Y. miR-451a inhibits cancer growth, epithelial-mesenchymal transition and induces apoptosis in papillary thyroid cancer by targeting PSMB8. J. Cell Mol. Med. 2019, 23, 8067–8075. [Google Scholar] [CrossRef] [Green Version]
- Pan, X.M.; He, X.Y. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 2453–2460. [Google Scholar]
- Haddad, R.; Nasr, C. NCCN Guidelines Insights Thyroid Carcinoma, Version 2.2018. J. Natl. Compr. Cancer Netw. 2018, 16, 1429–1440. [Google Scholar] [CrossRef] [Green Version]
- Celano, M.; Rosignolo, F. MicroRNAs as Biomarkers in Thyroid Carcinoma. Int. J. Genom. 2017, 2017, 6496570. [Google Scholar] [CrossRef] [Green Version]
- Zarkesh, M.; Zadeh-Vakili, A. Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes. Mol. Diagn Ther. 2018, 22, 41–56. [Google Scholar] [CrossRef] [PubMed]
miRNA | Sample Sources | Up/Down-Regulated | Targeted Gene | miRNA Effect on PTC Cells | Sponging/Sequestering | Potential Utility | References |
---|---|---|---|---|---|---|---|
miR-520a-3p | tissue | Down | JAK1 | prevented cell proliferation, migration, invasion, promoted apoptosis | TT | Bi. CL et al. [12] | |
miR-139-5p | tissue | Down | LMO4 | suppressed cell proliferation, migration, and tumor growth | circBACH2 | Pr, TT | Cai. X et al. [13] |
miR-128 | tissue | Down | SPHK1 | elevated apoptosis increased G0/G1 arrest, reduced Cyclin D1/ CDK4 expressions | - | TT | Cao. XZ et al. [14] |
miR-2861 | tissue | Up | DGCR5 | promoted cell proliferation and invasion | lncRNA DGCR5 | Pg | Chen. F et al. [15] |
miR-101 | tissue | Down | CXCL12 | repressed cell proliferation, migration, and invasion. Enhanced apoptosis | - | Pg, TT | Chen. F et al. [16] |
miR-135b-5p | tissue | Up | CCNG2 | modulated tumor cells proliferation, apoptosis, migration | lncRNA GAS8-AS1 | TT | Chen. N et al. [17] |
miR-202-3p | tissue | Down | WNT | suppressed the expression of β-catenin, cell migration, and invasion | - | TT | Chen. J et al. [18] |
miR-1271 | tissue | Up | IRS1 | suppressed migration, invasion, and proliferation of PTC cells | - | TT | Chen. Y et al. [19] |
miR-153-3p | tissue | Down | ZNRF2 | regulated cell proliferation, migration, and invasion | lncRNA TTN-AS1 | TT | Cui. Z et al. [20] |
miR-548c-3p | tissue | Down | HIF1α | reducted N-cadherin and vimentin expression | - | Pg, TT | Du. Y et al. [21] |
miR-150 | tissue | Down | MUC4 | suppressed PTC cell proliferation and metastasis | - | Dg, TT | Fa. Z et al. [22] |
Ex-miR-103 | blood | Up | GPER1 | influenced the differentiation of CD4 + T cell into Treg cells | - | TT | Fang. T et al. [23] |
miR-625-3p | tissue | Up | AEG-1 | promoted the proliferation, migration, and invasion of thyroid cancer cells | - | TT | Fang. L et al. [24] |
miR-141-3p | tissue | Down | YY-1 | inhibited cell growth, induced apoptosis, and suppressed invasion | - | Pg, TT | Fang. M et al. [25] |
miR-613 | tissue | Down | SphK2 | inhibited cell proliferation, migration, and invasion | lncRNA LINC00460 | TT | Feng. L et al. [26] |
miR-93-3p-660 | tissue | Up | FOXO1 | inhibited glycolysis that attenuated glucose uptake and lactate production | lncRNA ASMTL-AS1 | TT | Feng. Z et al. [27] |
miR-1266 | tissue | Down | FGFR2 | inhibited PTC cell proliferation, migration, and invasion | - | Dg, TT | Fu. YT et al. [28] |
miR-129 | tissue | Up | MAL2 | suppressed growth and invasion of PTC cells | - | Pv, TT | Gao. X et al. [29] |
miR-791 | tissue | Down | - | inhibited proliferation of PTC cells via blocking the G1 phase | - | Pg, TT | Gao. XB et al. [30] |
miR-429 | tissue | Down | ZEB1 | inhibited cell proliferation, migration, and invasion | lncRNA SNHG22 | Dg, TT | Gao. H et al. [31] |
miR-30a | tissue | Down | E2F7 | inhibited the proliferation, migration, and invasion of PTC cells | - | TT | Guo. H et al. [32] |
miR-9-5p | tissue | Down | BRAF | suppressed the viability of PTC cells by inducing apoptosis | - | TT | Guo. F et al. [33] |
miR-215 | tissue | Down | ARFGEF1 | inhibited proliferation and metastasis | - | Pg | Han. J et al. [34] |
Ex-miR-199 | blood | Down | DLG1-AS1 | suppressed proliferation of PTC cells | - | Dg | He. T et al. [35] |
miR-1252 | tissue | Up | FSTL1 | inhibited viability, proliferation, and stimulated apoptosis in PTC cells. | hsa_circ_ 0011290 | TT | Hu. Z et al. [36] |
miR-486-5p | tissue | Down | KIAA1199 | inhibited cell growth of PTC | - | TT | Jiao. X et al. [37] |
miR-885-5p | tissue | Down | RAC1 | suppressed PTC cell proliferation | hsa_circ_ 0004458 | TT | Jin. X et al. [38] |
miR-15a | tissue | Down | RET/AKT | inhibited PTC cell proliferation and invasion and enhanced the apoptosis | - | TT | Jin. J et al. [39] |
miR-381-3p | tissue | Down | LRP6 | inhibited the proliferation and metastasis of PTC cells | - | TT | Kong. W et al. [40] |
miR-485-5p | tissue | Down | Raf1 | inhibited PTC cell proliferation, migration and invasion | LncRNA LINC00460 | TT | Li. G et al. [41] |
miR-320a | cell culture | Up | HMGB1 | inhibited cell proliferation, migration and invasion rates | lncRNA ANRIL | Pv, TT | Li. M et al. [42] |
miR-369-3p | cell culture | Down | TSPAN13 | suppressed cell proliferation, colony formation, and induced apoptosis in PTC | - | Dg, Pv, TT | Li. P et al. [43] |
miR-205 | tissue | Down | YAP1 | inhibited proliferation and invasion of thyroid cancer cells | - | TT | Li. D et al. [44] |
miR-204-3p | tissue | Down | CDC23 | suppressed PTC proliferation, migration and invasion | lncRNA LINC00514 | TT | Li. X et al. [45] |
miR-361-5p | tissue | Down | ROCK1 | Inhibited proliferation, migration, and invasion | - | TT | Li. R et al. [46] |
miR-4500 | cell culture | Down | PLXNC1 | inhibited cell viability, colony formation, and cell apoptosis | - | Pg, TT | Li. R et al. [47] |
miR-211-5p | tissue | Down | SPARC | suppressed proliferation, migration, and invasion of thyroid tumor cells | lncRNA MCM3AP-AS1 | TT | Liang. M et al. [48] |
miR-101 | tissue | Down | FN1 | promoted the RAI-resistance in PTC | lncRNA-NEAT1 | TT | Liu. C et al. [49] |
miR-214 | tissue | Down | PSMD10 | suppressed proliferation, and induced cell apoptosis and cell cycle arrest in PTC cells | - | TT | Liu. F et al. [50] |
miR-744 | tissue | Down | NOB1 | attenuated the proliferation and invasion of PTC cells | - | TT | Liu. H et al. [51] |
miR-96-5p | tissue | Up | CCDC67 | accelerated the proliferation and metastasis of PTC cells | - | Dg, TT | Liu. ZM et al. [52] |
miR-4728 | cell culture | Down | SOS1 | repressed the PTC cell proliferation through MAPK | - | Dg, TT | Liu. Z et al. [53] |
miR-431 | tissue | Down | Gli1 | inhibited cell migration and invasion of PTC | - | TT | Liu. Y et al. [54] |
miR-524-5p | tissue | Down | FOXE1, ITGA3 | suppressed PTC progression by regulating tumor cell proliferation, migration, and invasion | - | TT | Liu. H et al. [55] |
miR-331-3p | tissue | Down | SLC25A1 | inhibited PTC cells proliferation, migration and invasion | lncRNA-BRM | TT | Liu. S et al. [56] |
miR-335-5p | tissue | Down | ICAM1 | reduced the proliferation, migration, invasion of PTC | - | TT | Luo. L et al. [57] |
miR-146a | tissue | - | GABPA | suppressed proliferation, migration, and invading capabilities of PTC cells | TT | Long. M et al. [58] | |
miR-29a-3p | tissue | Down | OTUB2 | suppressed growth, proliferation, invasion in PTC cells. | - | Pg, TT | Ma. Y et al. [59] |
miR-199a-5p | tissue | Down | SNAI1 | reduced migration and invasion of PTC cells | - | TT | Ma. S et al. [60] |
miR-363-3p | tissue | Down | ITGA6 | suppressed anoikis resistance in PTC cells | - | TT | Pan. Y et al. [61] |
miR-1231, miR-1304 | tissue | Down | - | inhibited proliferation and invasion of PTC cells | circ_ 0025033 | TT | Pan. Y et al. [62] |
miR-146b-5p | tissue | Up | DNMT3A | accelerated extra-glandular invasion and metastasis of PTC cells | lncRNA-MALAT1 | Dg, TT | Peng. Y et al. [63] |
miR-448 | tissue | Down | KDM5B | inhibited PTC cell progression and tumor growth via TGIF1 | - | TT | Pu. Y et al. [64] |
miR-199b-5p | tissue | Down | STON2 | inhibited PTC cell growth and metastasis | - | TT | Ren. L et al. [65] |
miR-26a-5p | tissue | Down | Wnt5a | inhibited proliferation, colony formation, invasion, and migration of PTC cells. | - | TT | Shi. D et al. [66] |
miR-564 | tissue | Down | AEG-1 | inhibited cell proliferation, migration, and invasion and induced cell apoptosis | - | TT | Song. Z et al. [67] |
miR-214-3p | tissue | Down | PSMD10 | impaired PTC cell proliferation and metastasis | lncRNA-SNHG3 | TT | Sui. G et al. [68] |
miR-144 | tissue | Down | WWTR1 | inhibited of PTC cell proliferation | - | Pg, TT | Sun. W et al. [69] |
miR-106b-5p | tissue | Down | ATAD2 | induced apoptosis and suppressed invasion of PTC cells | lncRNA-NEAT1_2 | TT | Sun. W et al. [70] |
miR-124-3p | cell culture | Down | MAP2K4 | inhibited the proliferation, induced apoptosis and cell cycle arrest in PTC cells | - | TT | Sun. Y et al. [71] |
miR-577 | tissue | Down | Sphk2 | inhibited PTC cell proliferation, migration, and invasion | lncRNA-LINC00520 | Dg, TT | Sun. Y et al. [72] |
miR-486 | tissue | Down | TENM1 | inhibited proliferation, invasion, and migration of PTC cell | - | TT | Sun. YH et al. [73] |
miR-497 | tissue | Down | BDNF | suppressed PTC cell proliferation, migration, and invasion | lncRNA-LINC00152 | TT | Sun. Z et al. [74] |
miR-22 | tissue | Up | - | promoted PTC cell metastasis and BRAFV600E mutation | - | Dg, Pg | Wang. D et al. [75] |
miR-599 | tissue | Down | Hey2 | diminished PTC cell proliferation, migration, invasion, while stimulating apoptosis | - | Pr, TT | Wang. DP et al. [76] |
miR-3619-5p | cell culture | Down | FOXM1 | regulated proliferation and apoptosis in PTC | lncRNA-Linc01410 | TT | Wang. G et al. [77] |
miR-675 | tissue | Down | MAPK1 | suppressed PTC cell proliferation, migration, and invasion | lncRNA-RMRP | TT | Wang. J et al. [78] |
miR-1258 | cell culture | Down | TMPRSS4 | inhibited cell viability, migration, and invasion | - | Dg, TT | Wang. L et al. [79] |
miR-451a | tissue | Down | ZEB1 | suppressed proliferation, mobility, and invasion of PTC cell | - | TT | Wang. Q et al. [80] |
miR-622 | tissue | Down | VEGFA | inhibited PTC cell proliferation, migration, and invasion | - | TT | Wang. R et al. [81] |
miR-212 | tissue | Down | MIAT | inhibited PTC cell proliferation, migration, and invasion. | (possible) lncRNA-MIAT | TT | Wang. R et al. [82] |
miR-718 | tissue | Down | PDPK1 | inhibited PTC cell growth, reduced cell invasion, repressed glucose metabolism | - | Dg, TT | Wang. X et al. [83] |
miR-31 | tissue | Down | SOX11 | repressed PTC cell proliferation, invasion, and migration | - | TT | Wang. Y et al. [84] |
miR-384 | tissue | Down | PRKACB | suppressed PTC cell proliferation and migration | - | TT | Wang. Y et al. [85] |
miR-873 | tissue | Down | CXCL16 | inhibited proliferation, migration, and invasion of the PTC cells | - | TT | Wang. Z et al. [86] |
miR-143-3p | tissue | Down | MSI2 | induced apoptosis, suppresses invasion and migration of PTC | - | TT | Wang. ZL et al. [87] |
miR-1261 | tissue | Down | C8orf4 | inhibited PTC cell proliferation, migration, and invasion | circZFR | TT | Wei. H et al. [88] |
miR-200a-3p | tissue | Down | YAP1 | inhibited PTC cell proliferation and promoted apoptosis | lncRNA-SNHG15 | TT | Wu. DM et al. [89] |
miR-329 | tissue | Down | WNT1 | decreased PTC cell proliferation, colony formation, suppressed growth | - | TT | Wu. L et al. [90] |
miR-203 | tissue | Down | Bcl-2 | inhibited cell proliferation, induced apoptosis, and suppressed the motility of PTC cells | - | TT | Wu. X et al. [91] |
miR-26a | tissue | Down | ROCK1 | repressed PTC cell viability, invasion, and metastasis | - | Dg, TT | Wu. YC et al. [92] |
miR-222 | tissue | Up | - | correlated with capsular invasion, vascular invasion, tumor size and metastasis | - | Pg | Xiang. D et al. [93] |
miR-150-5p | cell culture | Up | BRAF(V600E) | promoted PTC cell proliferation, suppressed apoptosis | - | TT | Yan. R et al. [94] |
miR-423-5p | cell culture | Down | SOX12 | suppressed PTC cell proliferation and invasion | lncRNA-NR2F1-AS1 | TT | Yang. C et al. [95] |
miR-182 | tissue | Up | CHL1 * | correlated with extrathyroidal invasion, cervical lymph node metastasis, and TNM | - | Pg | Yao. XG et al. [96] |
miR-1179 | tissue | - | HMGB1 | - | circFOXM1 | TT | Ye. M et al. [97] |
miR-1270 | cell culture | Up | SCAI | promoted PTC cell proliferation, migration | - | TT | Yi. T et al. [98] |
miR-761 | tissue | Down | TRIM29 | inhibited cell proliferation, and cell cycle progression in PTC | lncRNA- HOXA11-AS | TT | Yin. X et al. [99] |
miR-23a- | tissue | Down | CCNG1 | decreased proliferation, induced cell cycle arrest, and promoted PTC cell apoptosis | - | Dg, TT | Yin. JJ et al. [100] |
miR-203 | tissue | Down | AKT3 | suppressed cell migration and invasion in the PTC cells and promoted cell apoptosis | - | TT | You. A et al. [101] |
miR-3619-3p | tissue | Up | Wnt | promoted PTC cell migration and invasion | - | TT | Yu. S et al. [102] |
miR-637 | tissue | Down | Akt1 | inhibit inhibited PTC cell proliferation, invasion, and migration | lncRNA HOTTIP | Dg, TT | Yuan. Q et al. [103] |
miR-21 | tissue | Up | VHL | promoted PTC cell proliferation and invasion | - | TT | Zang. C et al. [104] |
miR-224-5p | tissue | Up | EGR2 | promoted PTC cell migration, invasion | - | Dg, TT | Zang. CS et al. [105] |
miR-509 | tissue | Down | PAX9 | inhibited cell proliferation and invasion in papillary thyroid carcinoma | - | TT | Zhang. S et al. [106] |
miR-766 | tissue | Down | IRS2 | inhibited proliferation of PTC cells | - | TT | Zhao. J et al. [107] |
miR-96-3p | tissue | Up | SDHB | increased the invasion and migration of PTC cells | TT | Zhao. X et al. [108] | |
miR-138-5p | tissue | Down | LRRK2 | inhibited PTC cell proliferation, apoptosis | lncRNA RP11-476D10.1 | TT | Zhao. Y et al. [109] |
miR-409-3p | tissue | Down | CCND2 | negatively regulated PTC cell proliferation and cell cycle progression | - | Pr, TT | Zhao. Z et al. [110] |
miR-200b/c | tissue | Down | Rap1b | inhibited PTC cell invasion, migration and growth | - | TT | Zhou. B et al. [111] |
miR-188-5p | tissue | Down | FGF-5 * | suppressed PTC cells growth | - | TT | Zhou. P et al. [112] |
miR-506 | tissue | Down | IL17RD | inhibited the proliferation, invasion, and migration capacities of PTC cells | - | Pg, TT | Zhu. J et al. [113] |
miR-146 | tissue | Up * | KIT | promoted PTC cell proliferation and invasion * | lncRNA CTC | TT | Liao. B et al. [114] |
miR-1178 | tissue | Up | TLR4 | promoted cell proliferation and suppressed cell apoptosis | circ_FNDC3B | TT | Wu. G et al. [115] |
miR-106a | tissue | Up | PTEN/ SFR4 | enhanced PTC cell proliferative, migratory and invasive abilities | lncRNA-HULC | TT | Yang. Z et al. [116] |
miR-335 | tissue | Down | SOX2 | suppressed the proliferation, migration, and invasion of PTC cells | lncRNA-LINC01510 | TT | Li. Q et al. [117] |
miR-199a-5p | tissue | Down | SLC1A5 | attenuated proliferation, induced apoptosis, and arrested cells in the G0/G1 phase | ABHD11-AS1 | Dg, TT | Zhuang. X et al. [118] |
miR-145-5p | tissue | Down | AKT3 | inhibited proliferation, migration and invasion | lncRNA-n384546 | Dg, TT | Feng. J et al. [119] |
miR-211 | tissue | Up | RECK | promoted tumor growth and increased tumor volume in PTC cells | - | Dg, Pg | Wei. ZL et al. [120] |
miR-206 | tissue | Down | MAP4K3 | enhanced Euthyrox sensitivity in Euthyrox-resistant PTC cells | - | TT | Liu. F et al. [121] |
miR-21-5p | cell culture | Up | TGFBI, COL4A1 | secreted by hypoxic PTC cells is a potent pro-angiogenic factor | - | Dg, TT | Wu. F et al. [122] |
Ex-miR-423-5p | blood | Up | - | promoted PTC cell migration and invasion | - | Dg, TT | Ye. W et al. [123] |
miR-422a | tissue | Down | SP1 | suppressed PTC cells proliferation and metastasis | lncRNA-LINC00313 | TT | Yan. D et al. [124] |
miR-1301-3p | tissue | Down | STAT3 | inhibited PTC cell proliferation, cell apoptosis -accelerated | lncRNA-ABDH11-AS1 | TT | Wen. J et al. [125] |
miR-let-7a | tissue | Down | c-Myc | suppressed PTC cell proliferation, migration, and invasion | - | TT | Huang. J et al. [126] |
miR-let-7e | tissue | Down | HMGB1 | inhibited of PTC cell growth and metastasis | - | TT | Ding. C et al. [127] |
miR-146b-5p | tissue | Up | CCDC6 | promoted proliferation, migration, invasion, and cell cycle progression of PTC cells | - | Dg, TT | Jia. M et al. [128] |
miR-145 | tissue | Down | ZEB2 | inhibited the migration, invasion, and tumorigenesis of PTC cells | circ_NUP214 | TT | Li. X et al. [129] |
miR-520c-3p | tissue | Down | S100A4 | inhibited PTC cells proliferation | lncRNA-HOXA-AS2 | TT | Xia. F et al. [130] |
miR-15a-5p | tissue | Down | - | inhibited PTC cells growth | lncRNA-HOXA-AS2 | TT | Jiang. L et al. [131] |
miR-146b-3p | tissue | Up | NF2 | increased PTC cell migration and invasion | - | TT | Yu. C et al. [132] |
miR-22a-3p | tissue | Up | CBL | promoted PTC cell proliferation and invasion | circ_ITCH | TT | Wang. M et al. [133] |
miR-21 | cell culture | - | PTEN | matrine- induced apoptosis and G1 cell cycle arrest | - | TT | Zhao. L et al. [134] |
miR-204 | tissue | Down | BRD4 | inhibited of PTC cell proliferation | lncRNA-UCA1 | TT | Li. D et al. [135] |
miR-4429 | tissue | Down | Bcl-2 | suppressed PTC cell proliferation, promoted apoptosis, and induced cell cycle arrest in G2/M phase | lncRNA-LINC00313 | TT | Wu. JW et al. [136] |
miR-222 | tissue | Up * | PPP2R2A | promoted PTC cell migration and invasion | - | Dg, TT | Huang. Y et al. [137] |
miR-21-5p | tissue | Down | Bcl-2 | inhibited TPC cell proliferation and invasion | lncRNA-BISPR | Dg, TT | Zhang. H et al. [138] |
miR-30a | tissue | Down | IGF1R | inhibited PTC cell proliferation, cycle progression, invasion, migration | lncRNA-PVT1 | TT | Feng. K et al. [139] |
miR-129-5p | tissue | Down | KLK7 | inhibited proliferation, cell survival, invasion, and migration | lncRNA-NEAT1 | TT | Zhang. H et al. [140] |
Ex-miR-146b-5p, Ex-miR-222-5p | blood | Down | - | enhanced the migration and invasion activity of PTC cells | - | Pg | Jiang. K et al. [141] |
miR-539 | tissue | Down | SLPI | inhibited PTC cell EMT and tumor growth | - | TT | Xu. CB et al. [142] |
miR-24-3p | tissue | Up | p27kip1 | regulated PTC cell proliferation, apoptosis migration and invasion | ncRNA-MIR22HG | TT | Chen. ZB et al. [143] |
miR-26a | cell culture | Down | ARPP19 | promoted proliferation of PTC cells | - | TT | Gong. Y et al. [144] |
Ex-miR-98-5p | blood | Down | HMGA2 | promoted PTC cell growth, inhibited apoptosis | - | Dg, Pg | Qiu. K et al. [145] |
miR-296-5p | tissue | Down | PLK1 | suppressed cell proliferation, inhibited cell clone formation, arrested the cell cycle in G2/M phase, and induced apoptosis | - | TT | Zhou. SL et al. [146] |
miR-451a | cell culture | Down * | PSMB8 | inhibited proliferation, EMT and induced apoptosis of PTC cells | - | TT | Fan. X et al. [147] |
miR-630 | tissue | Down | JAK2/ STAT3 | suppressed migration and invasion of PTC cells | - | TT | Pan. XM et al. [148] |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Hitu, L.; Gabora, K.; Bonci, E.-A.; Piciu, A.; Hitu, A.-C.; Ștefan, P.-A.; Piciu, D. MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020. Cancers 2020, 12, 3118. https://doi.org/10.3390/cancers12113118
Hitu L, Gabora K, Bonci E-A, Piciu A, Hitu A-C, Ștefan P-A, Piciu D. MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020. Cancers. 2020; 12(11):3118. https://doi.org/10.3390/cancers12113118
Chicago/Turabian StyleHitu, Liviu, Katalin Gabora, Eduard-Alexandru Bonci, Andra Piciu, Adriana-Cezara Hitu, Paul-Andrei Ștefan, and Doina Piciu. 2020. "MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020" Cancers 12, no. 11: 3118. https://doi.org/10.3390/cancers12113118
APA StyleHitu, L., Gabora, K., Bonci, E. -A., Piciu, A., Hitu, A. -C., Ștefan, P. -A., & Piciu, D. (2020). MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020. Cancers, 12(11), 3118. https://doi.org/10.3390/cancers12113118